These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30890279)

  • 1. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
    Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
    Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer.
    Shen X; Han J
    J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
    Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
    Liu Y; Zhang M; Liang L; Li J; Chen YX
    Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer.
    Fan XJ; Wan XB; Fu XH; Wu PH; Chen DK; Wang PN; Jiang L; Wang DH; Chen ZT; Huang Y; Wang JP; Wang L
    Tumour Biol; 2014 Oct; 35(10):10487-95. PubMed ID: 25056534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
    Yu MH; Luo Y; Qin SL; Zhong M
    Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sidedness of colorectal cancer on tumor immunity.
    Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
    PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
    Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
    Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer.
    Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X
    Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
    Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
    Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma.
    Wang Y; Wei J; Zhang S; Li G; Zhang T; Yu X; Chen H; Liu M
    Tumour Biol; 2015 Nov; 36(11):8781-7. PubMed ID: 26055144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of UQCRC2 is correlated with tumor progression and poor prognosis in colorectal cancer.
    Shang Y; Zhang F; Li D; Li C; Li H; Jiang Y; Zhang D
    Pathol Res Pract; 2018 Oct; 214(10):1613-1620. PubMed ID: 30115536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
    Yang L; Chen Z; Xiong W; Ren H; Zhai E; Xu K; Yang H; Zhang Z; Ding L; He Y; Song X; Liu J
    Hum Pathol; 2019 Feb; 84():62-70. PubMed ID: 30236596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.